The company expects to grant the initial buyers an option to buy up to an additional $90 million of notes.
Net proceeds will be used to repurchase a portion of the company's outstanding 4.00% convertible senior notes due 2026 and expand certain clinical development programs.
Price: 42.06, Change: -6.68, Percent Change: -13.71
|-- Earnings Flash (ANY) SPHERE 3D Posts Q2 Revenue $...|
|-- Earnings Flash (AWX) AVALON HOLDINGS CORPORATION ...|
|-- Earnings Flash (IKT) INHIBIKASE THERAPEUTICS Repo...|
|Research Alert: CFRA Retains Hold Opinion On Shares ...|
|US Stocks Climb as Inflation Expectations Wane|